Fasting Study of Valacyclovir Hydrochloride Tablets 1000 mg and Valtrex® Tablets 1000 mg
Status:
Completed
Trial end date:
2005-05-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to investigate the bioequivalence of Mylan's valacyclovir
hydrochloride 1000 mg tablets to GlaxoSmithKline's Valtrex® 1000 mg tablets following a
single, oral 1000 mg (1 x 1000 mg) dose administered under fasting conditions.